Jump to content

Tropical Health Network studies effectiveness of COVID-19 medicines


webfact

Recommended Posts

2b91312b4204de91ea68b1192efc64ef_small.jpg

 

By Tarin Angskul

   

BANGKOK (NNT) - Medical institutions in Thailand and the United Kingdom are joining hands to study the effectiveness of antiviral medicines against COVID-19.

 

The study focuses on 4 kinds of pills/treatments, including Favipiravir, Ivermectin, Remdesivir, and Regeneron.

 

The study’s technique can measure the reduction of the SARS-CoV-2 virus in COVID-19 patients who are treated with these 4 drugs.

 

The research project will be conducted in Thailand and around the world with 750 volunteers, 200 of who are in Thailand.

 

The objective is to find out which drugs are most effective or more effective than the others, giving the medical and healthcare sectors around the world an idea of which drugs they should opt for.

 

The study titled “Finding treatments for COVID-19: A phase 2 multi-center adaptive platform trial to assess antiviral pharmacodynamics in early symptomatic COVID-19 (PLATCOV)” is commissioned by the Faculty of Tropical Medicine, the Mahidol Oxford Tropical Medicine Research Unit, and partner hospitals.

 

Discover Cigna’s range of health insurance solutions created for expats and local nationals living in Thailand - click to view

 

nnt.jpg

 

Link to comment
Share on other sites

On 11/24/2021 at 3:12 PM, tinom said:

Great News that they study Ivermectin which would be my first choice and recommendation, it saves Japan now and has cleared Uttar Pradesh from covid despite only 5% vaxxed, El Salvador as well did distribute kits including it.
Meta analysis here https://ivmmeta.com

your link is to a disinformation site.

 

Your statement about Ivermectin working in Uttar Pradesh is junk. UP had so many Covid cases that they stopped reporting last May. Excess mortality data indicates mass casualties from Covid in Uttar Pradesh.

 

No, Ivermectin Did Not Help Japan Bring Down Covid-19 Coronavirus Delta Surge

 

On 11/24/2021 at 3:12 PM, tinom said:



 

 

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.







×
×
  • Create New...